Non categorizzato Eli Lilly launches $3.2B tender offer for Morphic Luglio 8, 2024 0 commenti Eli Lilly said on Monday that it will start a tender offer to acquire biopharmaceutical company Morphic for $57 per share in cash, or approximately $3.2 billion.Morphic is a biopharmaceutical company… About the author:
Get involved!
Comments